Ocular hemodynamic effects of nitrovasodilators in healthy subjects

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 1, 2010, Pages 87-92

  Schmidl, D ^a   Polska, E ^a   Kiss, B ^a   Sacu, S ^a   Garhofer, G ^a   Schmetterer, L ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PLACEBO; SODIUM CHLORIDE;

ADULT; ARTICLE; CHOROID; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFECT; EYE BLOOD FLOW; EYE FUNDUS; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OPTIC DISK; OPTIC NERVE; PERFUSION PRESSURE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; INTRAOCULAR PRESSURE; MALE; NITRIC OXIDE DONORS; OPTIC NERVE; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE; VASODILATOR AGENTS; YOUNG ADULT;

EID: 72849119502     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.186     Document Type: Article

References (44)

1. Grieshaber, M.C., Mozafarieh, M. & Flammer, J. What is the link between vascular dysregulation and glaucoma? Surv. Ophthalmol. 52 (suppl. 2), S144-S154 (2007).
2. Resch, H., Garhofer, G., Fuchsjäger-Mayrl, G., Hommer, A. & Schmetterer, L. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 87, 4-12 (2009).
3. Pemp, B. & Schmetterer, L. Ocular blood fow in diabetes and age-related macular degeneration. Can. J. Ophthalmol. 43, 295-301 (2008).
4. Feigl, B. age-related maculopathy-linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog. Retin. Eye Res. 28, 63-86 (2009).
5. Schmetterer, L. & Wolzt, M. Ocular blood fow and associated functional deviations in diabetic retinopathy. Diabetologia 42, 387-405 (1999).
6. Schmetterer, L. & Polak, K. Role of nitric oxide in the control of ocular blood fow. Prog. Retin. Eye Res. 20, 823-847 (2001).
7. Toda, N. & Nakanishi-Toda, M. Nitric oxide: ocular blood fow, glaucoma, and diabetic retinopathy. Prog. Retin. Eye Res. 26, 205-238 (2007).
8. Anderson, T.J., Meredith, I.T., Ganz, P. , Selwyn, A.P. & yeung, A.C. Nitric oxide and nitrovasodilators: similarities, diferences and potential interactions. J. Am. Coll. Cardiol. 24, 555-566 (1994).
9. Yao, K., Tschudi, M., Flammer, J. & Lüscher, T.F. Endothelium-dependent regulation of vascular tone of the porcine ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 32, 1791-1798 (1991).
10. Haefiger, I.O., Flammer, J. & Lüscher, T.F. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 33, 2340-2343 (1992).
11. Lockhart, C.J. et al. Nitric oxide modulation of ophthalmic artery blood fow velocity waveform morphology in healthy volunteers. Clin. Sci. 111, 47-52 (2006).
12. Meyer, P. , Flammer, J. & Lüscher, T.F. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest. Ophthalmol. Vis. Sci. 34, 3614-3621 (1993).
13. Donati, G., Pournaras, C.J., Munoz, J.L., Poitry, S., Poitry-yamate, C.L. & Tsacopoulos, M. Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest. Ophthalmol. Vis. Sci. 36, 2228-2237 (1995).
14. Mann, R.M., Riva, C.E., Stone, R.A., Barnes, G.E. & Cranstoun, S.D. Nitric oxide and choroidal blood fow regulation. Invest. Ophthalmol. Vis. Sci. 36, 925-930 (1995).
15. Luksch, A. et al. Efects of systemic NO synthase inhibition on choroidal and optic nerve head blood fow in healthy subjects. Invest. Ophthalmol. Vis. Sci. 41, 3080-3084 (2000).
16. Dorner, G.T. et al. Nitric oxide regulates retinal vascular tone in humans. Am. J. Physiol. Heart Circ. Physiol. 285, H631-H636 (2003).
17. Simader, C. et al. Role of NO in the control of choroidal blood fow during a decrease in ocular perfusion pressure. Invest. Ophthalmol. Vis. Sci. 50, 372-377 (2009).
18. Cohn, J.N. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure. Am. J. Cardiol. 72, 21C-24C; discussion 24C (1993).
19. Liu, S.X., Xuan, B.O., Chen, Z., Varma, R.S. & Chiou, G.C. Nitric oxide donors: efects of S-nitrosoglutathione and 4-phenyl-3-furoxancarbonitrile on ocular blood fow and retinal function recovery. J. Ocul. Pharmacol. Ther. 13, 105-114 (1997).
20. Grunwald, J.E., Iannaccone, A. & DuPont, J. Efect of isosorbide mononitrate on the human optic nerve and choroidal circulations. Br. J. Ophthalmol. 83, 162-167 (1999).
21. Iannaccone, A.E., DuPont, J. & Grunwald, J.E. Human retinal hemodynamics following administration of 5-isosorbide mononitrate. Curr. Eye Res. 20, 205-210 (2000).
22. Riva, C.E. & Schmetterer, L. Microcirculation of the ocular fundus. In Microcirculation 2 edn. (eds. Tuma, R.F. & Duran, W.N.) 735-766 (academic, St Louis, 2008).
23. Pournaras, C.J., Rungger-Brändle, E., Riva, C.E., Hardarson, S.H. & Stefansson, E. Regulation of retinal blood fow in health and disease. Prog. Retin. Eye Res. 27, 284-330 (2008).
24. Dallinger, S., Bobr, B., Findl, O., Eichler, H.G. & Schmetterer, L. Efects of acetazolamide on choroidal blood fow. Stroke 29, 997-1001 (1998).
25. Aaslid, R. Cerebral autoregulation and vasomotor reactivity. Front. Neurol. Neurosci. 21, 216-228 (2006).
26. Resch, H. et al. Efect of dual endothelin receptor blockade on ocular blood fow in patients with glaucoma and healthy subjects. Invest. Ophthalmol. Vis. Sci. 50, 358-363 (2009).
27. Benedict, N., Seybert, A. & Mathier, M.A. Evidence-based pharmacologic management of pulmonary arterial hypertension. Clin. Ther. 29, 2134-2153 (2007). (Pubitemid 350138566)
28. Ignarro, L.J. et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218, 739-749 (1981).
29. Miller, M.R. & Megson, I.L. Recent developments in nitric oxide donor drugs. Br. J. Pharmacol. 151, 305-321 (2007).
30. Chen, Z., Zhang, J. & Stamler, J.S. Identifcation of the enzymatic mechanism of nitroglycerin bioactivation. Proc. Natl. Acad. Sci. U.S.A. 99, 8306-8311 (2002).
31. Lundberg, J.O. & Weitzberg, E. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 25, 915-922 (2005).
32. Münzel, T. Recent fndings on nitrates: their action, bioactivation and development of tolerance. Dtsch. Med. Wochenschr. 133, 2277-2282 (2008).
33. Benkusky, N.A., Lewis, S.J. & Kooy, N.W. attenuation of vascular relaxation after development of tachyphylaxis to peroxynitrite in vivo. Am. J. Physiol. 275, H501-H508 (1998).
34. Schmetterer, L., Dallinger, S., Findl, O., Eichler, H.G. & Wolzt, M. a comparison between laser interferometric measurement of fundus pulsation and pneumotonometric measurement of pulsatile ocular blood fow. 1. Baseline considerations. Eye 14(Pt 1), 39-45 (2000).
35. Berisha, F., Findl, O., Lasta, M., Kiss, B. & Schmetterer, L. a study in healthy subjects comparing ocular pressure pulse and ocular fundus pulse in dependence of axial eye length and ocular volume. Acta Ophthalmol. (in press).
36. Polska, E. et al. Twelve hour reproducibility of choroidal blood fow parameters in healthy subjects. Br. J. Ophthalmol. 88, 533-537 (2004).
37. Luksch, A. et al. Twelve-hour reproducibility of retinal and optic nerve blood fow parameters in healthy individuals. Acta Ophthalmol. (in press).
38. Thomsen, L.L., Iversen, H.K., Emmeluth, C. & Bie, P. Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects. Eur. J. Clin. Pharmacol. 48, 139-142 (1995).
39. Sardina, M., Warrington, S.J., Boyce, M., Johnston, A. & Bianchini, C. Hemodynamic and humoral efects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study. J. Cardiovasc. Pharmacol. 26 (suppl. 4), S80-S90 (1995).
40. Nielsen, C.B., Eiskjaer, H. & Pedersen, E.B. Enhanced renal production of cyclic GMP and reduced free water clearance during sodium nitroprusside infusion in healthy man. Eur. J. Clin. Invest. 23, 375-381 (1993).
41. Riva, C.E., Harino, S., Petrig, B.L. & Shonat, R.D. Laser Doppler fowmetry in the optic nerve. Exp. Eye Res. 55, 499-506 (1992).
42. Riva, C.E., Cranstoun, S.D., Grunwald, J.E. & Petrig, B.L. Choroidal blood fow in the foveal region of the human ocular fundus. Invest. Ophthalmol. Vis. Sci. 35, 4273-4281 (1994).
43. Schmetterer, L. et al. Noninvasive investigations of the normal ocular circulation in humans. Invest. Ophthalmol. Vis. Sci. 39, 1210-1220 (1998).
44. Robinson, F., Riva, C.E., Grunwald, J.E., Petrig, B.L. & Sinclair, S.H. Retinal blood fow autoregulation in response to an acute increase in blood pressure. Invest. Ophthalmol. Vis. Sci. 27, 722-726 (1986).